Taken together, these data imply that observed decreases in PD-1 and CTLA-4 expression on PPD-specific CD4 T-cells are related to TB treatment, not ART, are pathogen-specific and does not represent generalized effects of TB therapy on total CD4 T-cells. The gene discussed is CTLA4; the disease is tuberculosis.